Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3Other solid neoplasm 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Melanoma 1Carcinoma, Renal Cell 1

Interventions

Nivolumab 24pembrolizumab 21Specimen Handling 17Ipilimumab 16Magnetic Resonance Spectroscopy 11CTLA-4 Antigen 8Opdualag 6Cyclophosphamide 6Biopsy 6trametinib 5relatlimab 5binimetinib 5fludarabine phosphate 4fludarabine 4dabrafenib 4cemiplimab 4atezolizumab 4X-Rays 4Paclitaxel 4Immunoglobulin G 4Disulfides 4Temozolomide 3Standard of Care 3Introns 3Interferon alpha-2 3Gemcitabine 3Carboplatin 3Blood Specimen Collection 3ulixertinib 2sargramostim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diet Therapy × Dermatologic × 30 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡